Side-by-side comparison of AI visibility scores, market position, and capabilities
SF YC S23 healthcare AI phone agents automating 50-70% of inbound calls for scheduling, prior auth, and claims; $5M Emergence Capital seed Sep 2025 with 4x revenue growth competing with Nuance and Luma Health for the $200B healthcare admin voice automation market.
Prosper AI is a San Francisco-based healthcare AI voice automation company — backed by Y Combinator (S23) with $5 million in seed funding in September 2025 led by Emergence Capital — providing healthcare providers with AI phone agents that automate inbound patient call workflows including patient scheduling, balance reminders, claims status checks, benefits verification, and prior authorization status inquiries — achieving 50-70% inbound call automation rates with 99% IVR navigation accuracy. Founded in 2023 by Josep Mingot and Xavier de Gracia (MIT and Harvard alumni), Prosper AI achieved 4x revenue growth since Q2 2025, addressing the $450 billion US healthcare administrative overhead crisis where an estimated $200 billion in administrative costs come from phone-based patient-provider communication inefficiencies.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.